Pharmesis International Ltd. announced consolidated earnings results for the year ended December 31, 2018. For the year, the company announced revenue of RMB 64,332,000 compared to RMB 69,727,000 a year ago. Profit for the year was RMB 5,059,000 compared to loss of RMB 1,826,000 a year ago. Basic and diluted earnings per share was 5.6 cents compared to basic and diluted loss per share of 10.8 cents a year ago.